US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,859.59

+14.720.80%

Number of Gainers:53

Number of Losers:43

Number of Flat:- -

PE:- -

High:1,866.76

Open:1,846.24

Low:1,846.24

Close:1,844.86

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Itron Unveils IntelliFLEX to Boost Grid Flexibility & DER Optimization

Microsoft : D.a. Davidson Raises to Buy From Neutral; Raises Target Price to $450 From $425

THOMSON REUTERS

RPT-BREAKINGVIEWS-Couche-Tard lobs ball back to Seven & i's court

Moderna Shares Slip 1.3% Premarket; Citigroup Initiates Coverage With "Neutral/High Risk" Rating

THOMSON REUTERS

These 20 stocks are likely to be losers no matter what the market does

Tech Stocks Are Plummeting: 2 Artificial Intelligence (AI) Stocks to Buy Now and Hold for Decades

BUZZ-Citigroup starts coverage on Moderna, notes risky path to profitability

Investors in Vodafone Group (LON:VOD) have unfortunately lost 27% over the last three years

Simply Wall St.

Hello Group: Strategic Financial Maneuvers and Growth Prospects Drive Buy Rating

BRIEF-Rockwell Automation Showcases Emulate3D Factory Test For The First Time At NVIDIA GTC 2025

Press Release: Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

Logistics Report: China Chides Walmart; Target Revamps Grocery Supply Chain

BRIEF-Bristol Myers Squibb To Report Results For First Quarter 2025 On April 24, 2025

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4532/news?page=33"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4532","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1859.5881,"timestamp":1742402833897,"preClose":1844.8641,"halted":0,"volume":369321963,"delay":0,"changeRate":0.007981,"change":14.723999,"pbRate":8.42931,"amount":41869604130.78451,"amplitude":0.01112,"prevYearClose":2026.1482,"fiveDayClose":1856.7594,"twentyDayClose":2068.769,"turnoverRate":0.00287,"marketCap":20733659493392,"floatMarketCap":19396278785408,"peRate":30.792522},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1866.7555,"amplitude":0.01112,"preClose":1844.8641,"low":1846.2399,"pbRate":"8.42931","latestPrice":1859.5881,"volume":369321963,"delay":0,"open":1846.2399,"prevYearClose":2026.1482,"prevWeekClose":1867.1416,"prevMonthClose":1965.7411,"prevQuarterClose":2026.1482,"fiveDayClose":1856.7594,"twentyDayClose":2068.769,"sixtyDayClose":2032.0883,"secType":"PLATE","market":"US","turnoverRate":0.00287,"peRate":30.792522,"marketCap":20733659493392,"floatMarketCap":19396278785408,"timestamp":1742402833897,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":53,"down":43,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:16,pageCount:33,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519831120","title":"Analysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831120?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:50","pubTimestamp":1741870234,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Werewolf Therapeutics (HOWL – Research Report) and E...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-werewolf-therapeutics-howl-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-werewolf-therapeutics-howl-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HOWL","EXEL","BK4137","HCSG","BK4139","BK4532","BK4539"],"gpt_icon":0},{"id":"2519832576","title":"Relative Price Strength: A Smart Strategy Amid Market Turmoil","url":"https://stock-news.laohu8.com/highlight/detail?id=2519832576","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519832576?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:19","pubTimestamp":1741868340,"startTime":"0","endTime":"0","summary":"The U.S. stock market, after a stellar run in 2023 and 2024, hit a rough patch in early 2025. February saw a sharp pullback, with the S&P 500 tumbling 1.4% and extending losses into March. Investors are becoming increasingly wary of the economic impact of Trump’s tariff policies, which could fuel inflation and slow down growth. The Federal Reserve has held off on further rate cuts, adding to market uncertainty. Meanwhile, concerns of a near-term recession have resurfaced, with the Atlanta Fed projecting a 2.8% contraction in first-quarter 2025.In this uncertain environment, relative price strength is proving to be a smart strategy for investors. Stocks that have held up well despite market turbulence often signal strong underlying fundamentals and continued demand. Companies with high relative price strength tend to outperform when market sentiment stabilizes. Identifying such stocks can help investors position themselves for potential upside while mitigating risks. As the broader mark","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relative-price-strength-smart-strategy-121900038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","BK4115","BK4559","BK4581","BK4588","BK4516","SPXU","ANIP","SPY","BK4023","VIRT","EVER","BK4021","VOO","BK4595","OEF","SSO","BK4007","IE00B7SZL793.SGD","ESmain","OEX","BK4127","SH","BK4600","BK4532","BK4504","OOMA","BK4534","BK4585","BK4596","IE00B66KJ199.SGD","STRK","MATX",".SPX","BK4077","IE0031619046.USD","SDS","IE00B19Z4B17.USD","IVV","BK4535"],"gpt_icon":1},{"id":"2519832629","title":"Itron Unveils IntelliFLEX to Boost Grid Flexibility & DER Optimization","url":"https://stock-news.laohu8.com/highlight/detail?id=2519832629","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519832629?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:14","pubTimestamp":1741868040,"startTime":"0","endTime":"0","summary":"Itron Inc. ITRI recently introduced IntelliFLEX, a cutting-edge grid-edge Distributed Energy Resource Management System  designed to provide real-time visibility, control and optimization of behind-the-meter DERs. By harnessing Grid-Edge Intelligence , IntelliFLEX helps utilities unlock up to 20% additional capacity in the distribution grid while deferring expensive infrastructure investments. This transformative solution will be showcased at DISTRIBUTECH 2025 from March 24-27.IntelliFLEX, part of ITRI’s GEI portfolio, is a flexible, end-to-end solution for near real-time DER optimization. It enables aggregation, forecasting and artificial intelligence -driven load balancing across AMI networks, DER aggregators and consumer energy assets. Key features include managing grid services, peak demand and flexible interconnections. IntelliFLEX works with Itron and third-party AMI networks or as a standalone system, helping utilities at any stage of grid modernization. When combined with distr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/itron-unveils-intelliflex-boost-grid-121400838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BMPRXR70.SGD","LU2286300806.USD","LU1974910355.USD","SG9999001424.SGD","LU1303367103.USD","IE00BN0W2T93.GBP","BK4585","LU0225283273.USD","IE00BN0W2W23.USD","IE00B2PGVK34.USD","LU1917777945.USD","BK4543","IE0008368304.USD","IE00B3CCJ633.GBP","LU0006306889.USD","LU0106261372.USD","UI","LU2048586759.USD","ANET","LU2023250504.SGD","ITRI","BK4023","BK4588","BK4532","IE00BMPRXN33.USD","LU2106854487.HKD","LU0348723411.USD","BK4554","IE00BGHQF417.EUR","LU2098885051.SGD","IE00BMPRXQ63.HKD","IDCC","IE00BN0W2V16.EUR","BK4020","BK4157"],"gpt_icon":0},{"id":"2519351468","title":"Microsoft : D.a. Davidson Raises to Buy From Neutral; Raises Target Price to $450 From $425","url":"https://stock-news.laohu8.com/highlight/detail?id=2519351468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519351468?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:09","pubTimestamp":1741867765,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d38accc82bdd7b58fc279a2d307eb12d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW15Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BSNM7G36.USD","LU2275660780.HKD","LU0096364046.USD","LU2403377893.USD","LU0719512351.SGD","IE0034235295.USD","LU1323610961.USD","BK4576","LU0289961442.SGD","LU2347655156.SGD","LU1935043536.SGD","LU0072461881.USD","LU1551013425.SGD","LU1633808545.USD","LU0345769128.USD","LU0426417589.USD","LU0494093205.USD","LU0557290698.USD","LU2023250843.SGD","LU0345770993.USD","LU0251132253.USD","IE00BYQQ9H92.USD","BK4525","IE0004445239.USD","BK4097","SG9999014567.USD","SGXZ23171101.USD","LU0689626769.HKD","LU2250418816.HKD","IE00B7KXQ091.USD","LU2279689827.SGD","LU0289739343.SGD","LU1188199696.SGD","BK4550","LU1084165304.USD","LU1934455194.USD","BK4567","LU2092627202.USD","LU1003077747.HKD","LU1267930730.SGD","LU0661504455.SGD","LU2750360997.AUD","LU2471134952.CNY","LU2168564149.EUR","LU1145028129.USD","LU2168564495.EUR","LU2077746001.SGD","MSFT","BK4532","LU0029864427.USD"],"gpt_icon":0},{"id":"2519583580","title":"RPT-BREAKINGVIEWS-Couche-Tard lobs ball back to Seven & i's court","url":"https://stock-news.laohu8.com/highlight/detail?id=2519583580","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519583580?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:00","pubTimestamp":1741867234,"startTime":"0","endTime":"0","summary":"RPT-BREAKINGVIEWS-Couche-Tard lobs ball back to Seven & i's courtThe author is a Reuters Breakingviews columnist.  The opinions expressed are his own. Updates to add graphic.By Hudson Lockett. HONG KONG, March 13  - What can you do when you can’t go hostile in a deal?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL6N3PW0BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4559","LU0345770308.USD","BK4113","LU0130102774.USD","LU0312595415.SGD","LU0302445910.USD","BK4504","LU0980610538.SGD","LU0648001328.SGD","KR","LU0345770993.USD","ACI","LU1201861249.SGD","BK4135","LU2275660780.HKD","BK4533","BK4532","APAM","BK4585","BK4588","LU0130517989.USD"],"gpt_icon":0},{"id":"2519112833","title":"Moderna Shares Slip 1.3% Premarket; Citigroup Initiates Coverage With \"Neutral/High Risk\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519112833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519112833?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:50","pubTimestamp":1741866612,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"446e3b75e9f970c0f10ea6de5c8047fb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW0WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4139","BK4532","BK4588","MRNA","BK4501","BK4533","BK4568","BK4534","BK4585","BK4551"],"gpt_icon":0},{"id":"2519833811","title":"These 20 stocks are likely to be losers no matter what the market does","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833811?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:45","pubTimestamp":1741866300,"startTime":"0","endTime":"0","summary":"Certain stocks are likely to lose money, even if the U.S. stock market stops declining and starts rising again.No one knows if the stock market decline that began on Feb. 19 will be the beginning of a major bear market, of course. But a recent study found that certain stocks are good bets to lose money, regardless of how the overall stock market performs. The study, entitled \"The Dynamics of Disagreement,\" was conducted by Kent Daniel of Columbia Business School, Alexander Klos of Germany's Kiel University and Simon Rottke of the University of Amsterdam. . On several occasions in recent years I've applied the study's methodology to stocks within the S&P 1500, constructing updated lists of Constrained Winners and Constrained Losers. The most recent list was published in early April 2024, and the stocks mentioned have performed as expected. The Constrained Winners list produced an average loss of 8.4% , while the Constrained Losers produced an average loss of 9.3%. Over the same period, ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4076","LU1861215975.USD","CLF","BK4170","BK4588","BK4548","BK4585","BK4568","BK4533","LU0053671581.USD","LU2065731478.USD","BK4006","BK4501","MRNA","BK4196","LU0149725797.USD","LU2211815571.USD","BK4177","GME","HIMS","BK4139","BK4547","LUMN","BK4554","CELH","BK4534","TPL","BK4543","BK4089","BK4551","LU1861220033.SGD","BK4577","SMCI","BK4213","BK4532","BK4535"],"gpt_icon":1},{"id":"2519083340","title":"Tech Stocks Are Plummeting: 2 Artificial Intelligence (AI) Stocks to Buy Now and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2519083340","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519083340?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:45","pubTimestamp":1741866300,"startTime":"0","endTime":"0","summary":"Technology stocks are under pressure as investors look to book profits in an uncertain economic scenario.The massive long-term opportunity in artificial intelligence means that the recent sell-off opened a potential buying opportunity as well.Two AI leaders are on track to deliver healthy long-term growth, making them ideal candidates to buy on the dip.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/13/tech-stocks-are-plummeting-2-artificial-intelligen/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BK4W5L77.USD","LU0444971666.USD","LU0642271901.SGD","LU0149725797.USD","LU0312595415.SGD","LU1868836914.USD","LU2065171402.SGD","BK4579","LU2417539215.USD","LU0316494557.USD","AIP","LU1935042991.SGD","SG9999015986.USD","SG9999014880.SGD","LU1043141123.HKD","LU0056508442.USD","LU1914381329.SGD","LU0094547139.USD","LU2462157665.USD","LU0466842654.USD","LU0980610538.SGD","LU0203345920.USD","IE00BHPRN162.USD","LU0080751232.USD","LU0957791311.USD","AI","LU1852331112.SGD","LU2236285917.USD","IE00BJLML261.HKD","LU1303367103.USD","LU0048573561.USD","LU2111349929.HKD","BK4532","IE0034235188.USD","LU0267386448.USD","IE00BK4W5M84.HKD","LU0323591593.USD","LU0107464264.USD","LU2098885051.SGD","LU2756315318.SGD","PLTR","LU1551013425.SGD","SG9999018865.SGD","LU1084165304.USD","LU1316542783.SGD","BK4566","LU0265550359.USD","LU2362541513.USD","PC"],"gpt_icon":1},{"id":"2519800508","title":"BUZZ-Citigroup starts coverage on Moderna, notes risky path to profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2519800508","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519800508?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:26","pubTimestamp":1741865215,"startTime":"0","endTime":"0","summary":"BUZZ-Citigroup starts coverage on Moderna, notes risky path to profitability** Citigroup starts coverage on vaccine maker Moderna MRNA.O with \"neutral/high risk\" rating and $40 PT, which represents a 14.3% upside to stock's last close** Company's transition away from its respiratory vaccine franchise will be challenging, with \"breakeven on a cash-cost basis is not internally projected to be until 2028\" - brokerage** Moderna's sales will remain primarily from its currently marketed respiratory vaccines, Spikevax and mRESVIA, with estimated sales of $1.4 bln and $1.1 bln in 2032, Citigroup says** \"Seasonality factors continue to have an impact\" on company's business, making its path to profitability \"risky\" due to fluctuations in demand and inventory management - brokerage** Says company's next-gen COVID and COVID+flu combo vaccines are expected to be approved in 2025, but are unlikely to be major growth drivers** Shares fell 63% in 2024  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4501","BK4139","BK4534","BK4548","BK4585","BK4588","MRNA","BK4533","BK4532","BK4551"],"gpt_icon":1},{"id":"2519836673","title":"Investors in Vodafone Group (LON:VOD) have unfortunately lost 27% over the last three years","url":"https://stock-news.laohu8.com/highlight/detail?id=2519836673","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519836673?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:20","pubTimestamp":1741864846,"startTime":"0","endTime":"0","summary":"For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term Vodafone Group Public Limited Company  shareholders, since the share price is down 44% in the last three years, falling well short of the market return of around 19%.Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.It's good to see that Vodafone Group has rewarded shareholders with a total shareholder return of 14% in the last twelve months. And that does include the dividend. That certainly beats the loss of about 1.0% per year over the last half decade. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a  inflection","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-vodafone-group-lon-vod-112046598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4132","BK4532","BK4585","ISBC","VOD","BK4588","BK4211"],"gpt_icon":0},{"id":"2519800058","title":"Hello Group: Strategic Financial Maneuvers and Growth Prospects Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519800058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519800058?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:15","pubTimestamp":1741864544,"startTime":"0","endTime":"0","summary":"Hello Group (MOMO – Research Report), the Communication Services sector company, was revisited by a Wall Street analyst today. Analyst Fawne Jiang ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hello-group-strategic-financial-maneuvers-and-growth-prospects-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hello-group-strategic-financial-maneuvers-and-growth-prospects-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4009","BK4585","BK4077","BK4532","BK4588","MOMO","BK4502","WIMI","BK4513","BK4531","BK4526","BK4508"],"gpt_icon":0},{"id":"2519609880","title":"BRIEF-Rockwell Automation Showcases Emulate3D Factory Test For The First Time At NVIDIA GTC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519609880","media":"Reuters","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519609880?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:15","pubTimestamp":1741864512,"startTime":"0","endTime":"0","summary":"BRIEF-Rockwell Automation Showcases Emulate3D Factory Test For The First Time At NVIDIA GTC 2025March 13 (Reuters) - NVIDIA Corp NVDA.O:ROCKWELL AUTOMATION SHOWCASES EMULATE3D FACTORY TEST FOR THE FIR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUA5Z0MVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","SG9999015358.SGD","NVDD","LU1861220033.SGD","LU1721428933.USD","LU0957808578.USD","NVD","LU0080751232.USD","LU1116320737.USD","LU1267930730.SGD","SGXZ23171101.USD","NVDS.UK","NVDU","BK4141","LU1551013425.SGD","LU0345768740.USD","LU0965509010.AUD","LU0323591593.USD","LU1894683264.USD","LU2237438978.USD","LU1267930573.SGD","BK4532","BK4605","HK0000306701.USD","SNVD.UK","LU2430703178.SGD","3NVD.UK","BK4543","LU2750360997.AUD","LU1674673691.USD","NVD3.UK","NVDA","LU0310800379.SGD","SG9999014559.SGD","2NVD.UK","NVDY","LU0466842654.USD","LU0238689110.USD","LU0964807845.USD","IE00BFSS8Q28.SGD","NVDS","LU0345769631.USD","NVD2.UK","LU2602419157.SGD","LU0957791311.USD","LU0061474705.USD","LU2023250330.USD","ROK"],"gpt_icon":0},{"id":"2519880399","title":"Press Release: Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519880399","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519880399?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:11","pubTimestamp":1741864260,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  will announce results for the first quarter of 2025 on Thursday, April 24, 2025. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET.Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU1670710661.SGD","LU1868837136.USD","LU1670711040.USD","LU1868836757.USD","LU1868836591.USD","IE00BFXG1179.USD","LU1718418525.SGD","IE0002141913.USD","BK4581","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU1261432733.SGD","LU0306806265.USD","LU2125154935.USD","LU0306807586.USD","LU2133065610.SGD","LU1670711123.USD","LU0882574055.USD","LU0237698245.USD","LU0321505868.SGD","MYE","BK4007","IE0009355771.USD","LU1989771016.USD","LU1670710588.SGD","LU1430594728.SGD","LU1868836914.USD","LU1093756168.USD","LU0321505439.SGD","LU0868494617.USD","LU0114720955.EUR","LU1074936037.SGD","LU0225771236.USD","LU0225284248.USD","BK4534","IE00BJT1NW94.SGD","LU2242652126.USD","LU1868837300.USD","LU1291159041.SGD","LU1323610961.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","BMY","BK4559","BK4532","BK4585","IE00B2B36J28.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2519773887","title":"Logistics Report: China Chides Walmart; Target Revamps Grocery Supply Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=2519773887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519773887?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:03","pubTimestamp":1741863780,"startTime":"0","endTime":"0","summary":"China Chides Walmart; Target Revamps Grocery Supply Chain By Mark R. Long. Chinese authorities this week summoned and rebuked Walmart officials following complaints that the U.S. retail giant was leaning on some Chinese suppliers to cut prices to help it absorb the cost of U.S. tariffs.The WSJ's Hannah Miao and Raffaele Huang write that President Trump's decision to add a 20% tariff on Chinese imports on top of previous duties puts retailers like Walmart in a jam . Raising prices to recoup higher costs risks angering Trump and consumers, but getting suppliers to eat the higher costs isn't easy, either.China is under pressure, too, as the tariffs inflict pain on the country's export-dependent economy, which already is wrestling with overproduction and weak domestic demand. Some American businesses have been cutting their dependence on China as relations have deteriorated.Target used to rely on grocery wholesalers. The company said switching to its own food-distribution centers has given","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU0265550946.USD","NEX.SI","BK6039","LU0640476718.USD","LU2471134523.USD","LU2360032135.SGD","LU0211328371.USD","LU2471134796.USD","BK4597","LU1066051811.HKD","LU0211327993.USD","BK4581","LU1066053197.SGD","LU1814569148.SGD","LU1116320737.USD","IE000M9KFDE8.USD","LU1035773651.USD","LU2505996681.GBP","LU2471134879.HKD","LU2461242641.AUD","LU0289960550.SGD","BK4504","BK4596","BK4588","LU1430594728.SGD","LU1069347547.HKD","LU2471134952.CNY","LU1366192091.USD","LU2750360997.AUD","LU2430703095.HKD","IE0034235188.USD","LU2592432038.USD","BK4585","LU1267930490.SGD","BK4532","LU0175139822.USD","LU0417517546.SGD","LU1280957306.USD","BK4534","BK4533","BBC","LU1988902786.USD","LU2361044949.HKD","LU1064131342.USD","LU2125154778.USD","LU2125154935.USD","LU2361045086.USD","LU2430703251.USD","WMT"],"gpt_icon":1},{"id":"2519887436","title":"BRIEF-Bristol Myers Squibb To Report Results For First Quarter 2025 On April 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887436","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887436?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:01","pubTimestamp":1741863703,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb To Report Results For First Quarter 2025 On April 24, 2025March 13 (Reuters) - Bristol-Myers Squibb Co BMY.N:BRISTOL MYERS SQUIBB TO REPORT RESULTS FOR FIRST QUARTER 2025 ON","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUA7VZDRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BFXG1179.USD","LU1093756168.USD","LU0225771236.USD","LU2360032135.SGD","IE0009355771.USD","LU0306807586.USD","LU1323610961.USD","LU0306806265.USD","LU0114720955.EUR","LU0456855351.SGD","LU1430594728.SGD","BK4007","LU1670711123.USD","LU1989771016.USD","LU1670710588.SGD","BK4559","LU0096364046.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0321505439.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0882574055.USD","BK4585","LU1291159041.SGD","LU2133065610.SGD","LU2242652126.USD","LU0237698245.USD","LU1074936037.SGD","LU2242646821.SGD","LU1868837300.USD","BK4532","LU1585245621.USD","LU0868494617.USD","LU2125154935.USD","IE0002141913.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU0985481810.HKD","LU0225284248.USD","LU1868836591.USD","LU1718418525.SGD","BMY","IE00BJJMRZ35.SGD","LU1571399168.USD","BK4581","LU1261432733.SGD","LU1868836757.USD"],"gpt_icon":0},{"id":"2519617835","title":"EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2519617835","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519617835?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863637,"startTime":"0","endTime":"0","summary":"On Thursday, Vivani Medical, Inc.  announced the administration of its first GLP-1  implant in the LIBERATE-1 trial in Australia.Vivani's lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1  implant under development for chronic weight management in obese or overweight individuals.Also Read: EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value. The company also announced full enrollment in the LIBERATE-1 study, which was achieved four weeks after the first subject enrolled, and reaffirmed that top-line results should be available in mid-2025.In December, Vivani Medical initiated screening and enrollment at two centers in Australia for the first-in-human LIBERATE-1 trial.The LIBERATE-1 study is exploring the full pharmacokinetic profile of NPM-115, which has demonstrated consistently smooth and minimally fluctuating drug release in vitro and in animal models.LIBERATE-1 is a Phas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-vivani-medical-announces-first-110037673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU2456880835.USD","IE00BKVL7J92.USD","LU0154236417.USD","BK4082","LU1093756325.SGD","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","BK4588","BK4590","SSI","LU2462157665.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","GLP","AZN","BK4144","BK4568","BK4599","BK4007","LU2236285917.USD","VANI","BK4532","LU0889565916.HKD","BK4585"],"gpt_icon":1}],"pageSize":16,"totalPage":84,"pageCount":33,"totalSize":1331}]}}